Holly Anderton
Walter and Eliza Hall Institute (WEHI), VIC, Australia
I completed my undergraduate study at The University of Canterbury achieving a BA in Philosophy and a BSc(hons) in biochemistry and microbiology. I’ve worked for 12 years in a world leading molecular biology lab, currently based at the WEHI, where I have contributed substantially to projects refining our understanding of TNF signalling, and the apoptotic and necroptotic cell death pathways. In 2019 I completed my PhD on the role of TNF superfamily in skin development and homeostasis from The University of Melbourne. My current and long-term research interests involve developing a comprehensive understanding of what initiates and drives inflammation in the skin. I’m interested in the mechanisms of skin disease on a molecular level, while also considering the wider, more complex cellular interactions, and the role of the microbial micro-environment.
Presentations this author is a contributor to:
TRAF2 regulates NFĸB transcription factors to inhibit cell death and inflammation in the skin (#47)
6:00 PM
Nima Etemadi
Poster Session 1
Inhibitor of apoptosis (IAP) proteins repress spontaneous inflammatory joint disease (#286)
6:00 PM
Kate Lawlor
Poster Session 1